Literature DB >> 29156226

Frequency of brain MRI abnormalities in neuromyelitis optica spectrum disorder at presentation: A cohort of Latin American patients.

Edgar Carnero Contentti1, Vanessa Daccach Marques2, Ibis Soto de Castillo3, Veronica Tkachuk4, Amilton Antunes Barreira2, Elizabeth Armas5, Edson Chiganer6, Camila de Aquino Cruz2, José Luis Di Pace6, Javier Pablo Hryb6, Carolina Lavigne Moreira2, Carmen Lessa6, Omaira Molina3, Monica Perassolo6, Arnoldo Soto5, Alejandro Caride7.   

Abstract

BACKGROUND: Brain magnetic resonance imaging (BMRI) lesions were classically not reported in neuromyelitis optica (NMO). However, BMRI lesions are not uncommon in NMO spectrum disorder (NMOSD) patients.
OBJECTIVE: To report BMRI characteristic abnormalities (location and configuration) in NMOSD patients at presentation.
METHODS: Medical records and BMRI characteristics of 79 patients with NMOSD (during the first documented attack) in Argentina, Brazil and Venezuela were reviewed retrospectively.
RESULTS: BMRI abnormalities were observed in 81.02% of NMOSD patients at presentation. Forty-two patients (53.1%) showed typical-NMOSD abnormalities. We found BMRI abnormalities at presentation in the brainstem/cerebellum (n = 26; 32.9%), optic chiasm (n = 16; 20.2%), area postrema (n = 13; 16.4%), thalamus/hypothalamus (n = 11; 13.9%), corpus callosum (n = 11; 13.9%), periependymal-third ventricle (n = 9; 11.3%), corticospinal tract (n = 7; 8.8%), hemispheric white matter (n = 1; 1.2%) and nonspecific areas (n = 49; 62.03%). Asymptomatic BMRI lesions were more common. The frequency of brain MRI abnormalities did not differ between patients who were positive and negative for aquaporin 4 antibodies at presentation.
CONCLUSION: Typical brain MRI abnormalities are frequent in NMOSD at disease onset.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Latin America; Magnetic resonance imaging; Neuromyelitis optica spectrum disorders; Typical MRI abnormalities

Mesh:

Substances:

Year:  2017        PMID: 29156226     DOI: 10.1016/j.msard.2017.11.004

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  5 in total

1.  Chronic Cognitive Impairment in AQP4+ NMOSD With Improvement in Cognition on Eculizumab: A Report of Two Cases.

Authors:  Georges Saab; David G Munoz; Dalia L Rotstein
Journal:  Front Neurol       Date:  2022-05-13       Impact factor: 4.086

Review 2.  Magnetic resonance imaging in neuromyelitis optica spectrum disorder.

Authors:  Laura Clarke; Simon Arnett; Kate Lilley; Jacky Liao; Sandeep Bhuta; Simon A Broadley
Journal:  Clin Exp Immunol       Date:  2021-07-06       Impact factor: 4.330

Review 3.  Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis.

Authors:  Nadja Borisow; Masahiro Mori; Satoshi Kuwabara; Michael Scheel; Friedemann Paul
Journal:  Front Neurol       Date:  2018-10-23       Impact factor: 4.003

4.  Alterations in the Brain Structure and Functional Connectivity in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder.

Authors:  Jueyue Yan; Yu Wang; Hanpei Miao; William Robert Kwapong; Yi Lu; Qingkai Ma; Wei Chen; Yunhai Tu; Xiaozheng Liu
Journal:  Front Neurosci       Date:  2020-01-14       Impact factor: 4.677

5.  Neutrophil-to-Lymphocyte Ratio on Admission is an Independent Risk Factor for the Severity of Neurological Impairment at Disease Onset in Patients with a First Episode of Neuromyelitis Optica Spectrum Disorder.

Authors:  Yongyan Zhou; Haojie Xie; Yi Zhao; Jinwei Zhang; Yanfei Li; Ranran Duan; Yaobing Yao; Yanjie Jia
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-18       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.